Sorry, you need to enable JavaScript to visit this website.

December Social Media Round-Up—Welcome Seagen, US/India CEO Forum, AI, and Gratitude

image of panel of CEO executives from the India-US CEO Forum

The last month of the year tends to be rather hectic, as the holidays descend and everyone scrambles to wrap things up before spending time with their families, friends, and loved ones. Here at Pfizer, December was just as action-packed as the rest of the year. In our monthly round-up of our leadership’s social media activity, Pfizer’s CEO speaks about the acquisition of Seagen, the Nobel Prize committee honors a pair of scientists integral to development of the COVID-19 vaccine, Pfizer’s work receives special recognition from Ireland, and more!

Catch up below!

From Our Leadership

CEO Albert Bourla welcomes Seagen as Pfizer’s acquisition is finalized:

Chief Digital and Technology Officer Lidia Fonseca reports on her conversation about AI with Amazon Web Services (AWS) CEO Adam Selipsky at the #reInvent conference:

CEO Albert Bourla attended the US-India CEO forum from the U.S. Department of Commerce:

Chief Scientific Officer Mikael Dolsten reflects on the Nobel Prize Ceremony that honored the scientists behind Pfizer’s mRNA breakthrough:

President of Rare Diseases Bert Bruce reiterates Pfizer’s commitment to the Sickle Cell community:

Albert Bourla accepts IDA Ireland’s Special Recognition Reward:

Chief Corporate Affairs Officer Sally Susman shares her an essay she wrote for MSNBC, all about giving the gift of gratitude this holiday season:

    Albert Bourla Covid-19 Leadership Oncology Rare Diseases